Product

Cagrilintide and Semaglutide

2 clinical trials

1 indication

Indication

Clinical trial

An Investigation of the Effect of Cagrilintide and Semaglutide Combination Treatment (CagriSema) on Appetite and Functional Brain Activity in People With Overweight or Obesity

Status: Recruiting, Estimated PCD: 2026-01-19

Clinical trial

Investigation of Pharmacokinetics Following Co-administration of Cagrilintide (NNC0174-0833) and Semaglutide Versus Separate Injections in Subjects With Overweight or Obesity

Status: Completed, Estimated PCD: 2022-01-19